Goldstone Financial Group LLC grew its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 14.4% in the fourth quarter, HoldingsChannel reports. The fund owned 6,210 shares of the company’s stock after buying an additional 781 shares during the period. Goldstone Financial Group LLC’s holdings in Colgate-Palmolive were worth $565,000 as of its most recent filing with the SEC.
Several other institutional investors have also bought and sold shares of the stock. D Orazio & Associates Inc. increased its stake in shares of Colgate-Palmolive by 3.9% during the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock valued at $297,000 after acquiring an additional 108 shares during the period. Fiducient Advisors LLC boosted its stake in Colgate-Palmolive by 5.2% during the 3rd quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock valued at $232,000 after purchasing an additional 110 shares in the last quarter. Sequoia Financial Advisors LLC increased its position in shares of Colgate-Palmolive by 0.6% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock valued at $2,117,000 after purchasing an additional 113 shares during the period. Great Waters Wealth Management raised its stake in shares of Colgate-Palmolive by 1.5% in the 3rd quarter. Great Waters Wealth Management now owns 7,669 shares of the company’s stock worth $796,000 after buying an additional 117 shares in the last quarter. Finally, Waldron Private Wealth LLC boosted its stake in Colgate-Palmolive by 2.1% during the third quarter. Waldron Private Wealth LLC now owns 5,632 shares of the company’s stock valued at $585,000 after buying an additional 118 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.
Colgate-Palmolive Price Performance
CL stock opened at $88.61 on Friday. Colgate-Palmolive has a 12-month low of $79.69 and a 12-month high of $109.30. The stock has a market capitalization of $72.40 billion, a price-to-earnings ratio of 25.39, a PEG ratio of 3.01 and a beta of 0.44. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The firm’s 50-day moving average price is $92.32 and its two-hundred day moving average price is $97.85.
Colgate-Palmolive Dividend Announcement
Analyst Upgrades and Downgrades
A number of equities research analysts have weighed in on the stock. Wells Fargo & Company cut their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. TD Cowen cut their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Piper Sandler dropped their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. UBS Group dropped their price objective on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research note on Thursday. Finally, StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $102.11.
Check Out Our Latest Stock Analysis on CL
Insider Buying and Selling at Colgate-Palmolive
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.37% of the company’s stock.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- Financial Services Stocks Investing
- Top Growth Picks: 3 Low-Cost Stocks That Could Double in Value
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Is Johnson & Johnson Stock Set to Reward Long-Term Holders?
- The 3 Best Blue-Chip Stocks to Buy Now
- Buffett’s Sale of BAC Stock: A Smart Move or Missed Opportunity?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.